Credit Suisse Ag Gilead Sciences, Inc. Put Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $7.38 Million - $8.38 Million	113,800 Added 44.42%	370,000 $26.9 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $1.78 Million - $1.92 Million	26,300 Added 11.44%	256,200 $17.9 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $16.8 Million - $18.4 Million	-265,000 Reduced 53.55%	229,900 $15.8 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $18.2 Million - $20.7 Million	-302,600 Reduced 37.94%	494,900 $32 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $4.65 Million - $5.3 Million	82,100 Added 11.48%	797,500 $46.5 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $30.8 Million - $38.7 Million	495,400 Added 225.18%	715,400 $45.2 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $6.5 Million - $7.54 Million	-89,800 Reduced 28.99%	220,000 $16.9 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $13 Million - $16.6 Million	-207,400 Reduced 40.1%	309,800 $23.2 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.4 Million - $1.55 Million	-22,800 Reduced 4.22%	517,200 $33.6 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $7.35 Million - $8.11 Million	-117,600 Reduced 17.88%	540,000 $34.2 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $16.3 Million - $18.3 Million	263,100 Added 66.69%	657,600 $44.4 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $4.53 Million - $5.08 Million	72,500 Added 22.52%	394,500 $25.6 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $1.31 Million - $1.71 Million	-21,600 Reduced 6.29%	322,000 $20.1 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $605,880 - $670,820	-8,500 Reduced 2.41%	343,600 $26.5 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $20 Million - $23.4 Million	-308,600 Reduced 46.71%	352,100 $24.9 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $5.15 Million - $6.28 Million	-70,700 Reduced 9.67%	660,700 $49.8 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $52.2 Million - $61.3 Million	-733,600 Reduced 50.08%	731,400 $52.4 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $32.8 Million - $38.9 Million	455,000 Added 45.05%	1,465,000 $119 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,010,000	1,010,000 $71.5 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account